Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) Investor Alert: Lawsuit to Halt Takeover at $9.50 Per Share
An investor, who currently hold shares of Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) filed a lawsuit in effort to halt the proposed takeover of Cornerstone Therapeutics, Inc. by Chiesi Farmaceutici SpA for $9.50 per NASDAQ:CRTX share.
View full press release